RE:Exro Announces Filing of a Final Base Shelf Prospectus I find this very interesting. This instrument is only good for securities issued in Canada to Canadians.
It seems at odds with EXRO's intent to list in the US on NASDAQ in Q1 of 2022.
And one of the principal purposes of that move is to broaden access to growth capital.
I would like to know the thinking behind the timing of this filing given the above.
Any thoughts?